Actinoplanes sp. A1094 strain had been selected for its high production of acarbose from 20 different strains of Actinoplanes sp. can be found in wild. The content for glucosidase inhibitor of acarbose concentration was recorded at 1.12 g/L. The conducted analysis of 16S rRNA sequence of Actinoplanes sp. A1094 showed 99% similar identity to the corresponding sequence of Actinoplanes hulinensis. Acarbose was purified from Actinoplanes hulinensis 1094 with a yield of 8.48%, purity of 98% and further identified by LC/MS and NMR methods (CHNO; m/z: 645.6 g/mol). The purified acarbose was used to evaluate the hypoglycemia in streptozotocin (STZ)-induced diabetic mice model. The purified acarbose reduced postprandial blood glucose level in comparison with Glucobay® as medication for control type 2 diabetes in a combination therapy. Notably, the outcomes of native acarbose on fasting blood glucose levels in mice resemble akin to the commercial product and the acarbose accumulating fermentation and metabolic engineering from the cell gene in which would reduce in production cost. Therefore, acarbose from Actinoplanes hulinensis 1094 could be potentially used to make products for the treatment of type II diabetes.Copyright © 2020 Elsevier Ltd. All rights reserved.
About The Expert
Do Thi Tuyen
Guo Yong Yew
Nguyen Tien Cuong
Le Thanh Hoang
Hoang Thi Yen
Phan Thi Hong Thao
Nguyen Thi Thao
Nguyen Sy le Thanh
Nguyen Thi Hien Trang
Nguyen Thi Trung
Ruqayya Afridi
Dao Thi Mai Anh
Pau Loke Show
References
PubMed